{"id":"NCT00321737","sponsor":"Takeda","briefTitle":"Efficacy and Safety of Dexlansoprazole MR Compared to Placebo on Maintaining Healing in Subjects With Healed Erosive Esophagitis","officialTitle":"A Phase 3 Study to Evaluate the Safety and Efficacy of TAK-390MR (30 mg QD and 60 mg QD) Compared to Placebo in Maintenance of Healing in Subjects With Healed Erosive Esophagitis.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-05","primaryCompletion":"2007-05","completion":"2007-05","firstPosted":"2006-05-04","resultsPosted":"2009-08-28","lastUpdate":"2012-02-03"},"enrollment":445,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Esophagitis, Reflux","Esophagitis, Peptic"],"interventions":[{"type":"DRUG","name":"Dexlansoprazole MR","otherNames":["TAK-390MR","Kapidex","Dexilant"]},{"type":"DRUG","name":"Dexlansoprazole MR","otherNames":["TAK-390MR","Kapidex","Dexilant"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Dexlansoprazole MR 30 mg QD","type":"EXPERIMENTAL"},{"label":"Dexlansoprazole MR 60 mg QD","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to assess the ability of once-daily (QD) treatment with dexlansoprazole modified release (MR) 30 mg and 60 mg or placebo in maintaining healing of erosive esophagitis (EE).","primaryOutcome":{"measure":"Percentage of Subjects Who Maintained Complete Healing of Erosive Esophagitis as Assessed by Endoscopy - Crude Rate Analysis.","timeFrame":"6 months","effectByArm":[{"arm":"Placebo QD","deltaMin":14.3,"sd":null},{"arm":"Dexlansoprazole MR 30 mg QD","deltaMin":66.4,"sd":null},{"arm":"Dexlansoprazole MR 60 mg QD","deltaMin":66.4,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.00001"},{"comp":"OG000 vs OG002","p":"<0.00001"},{"comp":"OG001 vs OG002","p":">0.99999"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":8},"locations":{"siteCount":98,"countries":["United States","Australia","Canada","Czechia","Estonia","Latvia","Lithuania","Slovakia"]},"refs":{"pmids":["19210298","19735233","20195905","21129076"],"seeAlso":["http://general.takedapharm.com/content/file/pi.pdf?applicationcode=9efb34b3-fb69-4190-a2be-a90b8cb94e25&filetypecode=DEXILANTPI"]},"adverseEventsSummary":{"seriousAny":{"events":1},"commonTop":["Upper Respiratory Tract Infections","Gastritis (Excl Infective)","Diarrhoea (Excluding [Excl] Infective)","Musculoskeletal and Connective Tissue Signs and Symptoms NEC","Joint Related Signs and Symptoms"]}}